A case study of embryonal rhabdomyosarcoma in children with frontal-parietal lobe metastases

References:

[1] Shern JF, Chen L, Chmielecki J, et al.Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors[J].Cancer Discov, 2014, 4(2):216-231.DOI:10.1158/2159-8290.CD-13-0639.
[2] Shern JF, Selfe J, Izquierdo E, et al.Genomic classification and clinical outcome in rhabdomyosarcoma:a report from an international consortium[J].J Clin Oncol, 2021, 39(26):2859-2871.DOI:10.1200/JCO.20.03060.
[3] Agaram NP.Evolving classification of rhabdomyosarcoma[J].Histopathology, 2022, 80(1):98-108.DOI:10.1111/his.14449.
[4] Anderson WJ, Doyle LA.Updates from the 2020 World Health Organization classification of soft tissue and bone tumours[J].Histopathology, 2021, 78(5):644-657.DOI:10.1111/his.14265.
[5] Leiner J, Le Loarer F.The current landscape of rhabdomyosarcomas:an update[J].Virchows Arch, 2020, 476(1):97-108.DOI:10.1007/s00428-019-02676-9.
[6] Alaggio R, Zhang L, Sung YS, et al.A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma:identification of novel and recurrent VGLL2-related fusions in infantile cases[J].Am J Surg Pathol, 2016, 40(2):224-235.DOI:10.1097/PAS.0000000000000538.
[7] Agaram NP, Zhang L, Sung YS, et al.Expanding the spectrum of intraosseous rhabdomyosarcoma:correlation between 2 distinct gene fusions and phenotype[J].Am J Surg Pathol, 2019, 43(5):695-702.DOI:10.1097/PAS.0000000000001227.
[8] Perez EA, Kassira N, Cheung MC, et al.Rhabdomyosarcoma in children:a SEER population based study[J].J Surg Res, 2011, 170(2):e243-e251.DOI:10.1016/j.jss.2011.03.001.
[9] Sbaraglia M, Bellan E, Dei Tos AP.The 2020 WHO classification of soft tissue tumours:news and perspectives[J].Pathologica, 2021, 113(2):70-84.DOI:10.32074/1591-951X-213.
[10] Zhang Y, Chen MY, Huang DS, et al.Correlation between ARID1B gene mutation (p.A460, p.V215G) and prognosis of high-risk refractory neuroblastoma[J].Cell Biol Int, 2023, 47(7):1222-1228.DOI:10.1002/cbin.12013.
[11] Tessier-Cloutier B, Kommoss FKF, Kolin DL, et al.Dedifferentiated and undifferentiated ovarian carcinoma:an aggressive and molecularly distinct ovarian tumor characterized by frequent SWI/SNF complex inactivation[J].Mod Pathol, 2024, 37(1):100374.DOI:10.1016/j.modpat.2023.100374.
[12] Song JL, Xu RY, Zhang H, et al.Cell-in-cell-mediated entosis reveals a progressive mechanism in pancreatic cancer[J].Gastroenterology, 2023, 165(6):1505-1521.e20.DOI:10.1053/j.gastro.2023.08.035.
[13] Zhu YC, Wang WX, Li XL, et al.Identification of a novel icotinib-sensitive EGFR-SEPTIN14 fusion variant in lung adenocarcinoma by next-generation sequencing[J].J Thorac Oncol, 2019, 14(8):e181-e183.DOI:10.1016/j.jtho.2019.03.031.
[14] Nguyen D, Haley L, Pallavajjala A, et al.Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia[J].Leuk Lymphoma, 2018, 59(1):265-267.DOI:10.1080/10428194.2017.1324163.
[15] Missiaglia E, Williamson D, Chisholm J, et al.PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification[J].J Clin Oncol, 2012, 30(14):1670-1677.DOI:10.1200/JCO.2011.38.5591.
[16] Bisogno G, Ferrari A, Prete A, et al.Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma[J].Eur J Cancer, 2009, 45(17):3035-3041.DOI:10.1016/j.ejca.2009.08.019.
[17] Rodriguez-Beato F, De Jesus O, Sanchez-Ortiz J, et al.Alveolar rhabdomyosarcoma metastatic to the brain[J].BMJ Case Rep, 2021, 14(3):e240516.DOI:10.1136/bcr-2020-240516.
[18] De B, Kinnaman MD, Wexler LH, et al.Central nervous system relapse of rhabdomyosarcoma[J].Pediatr Blood Cancer, 2018, 65(1):26710.DOI:10.1002/pbc.26710.